Lipogems, a clinical stage- global medical technology company that utilizes autologous adipose tissue for therapeutic use in orthopaedics and other specialties announces it has...
Akebia Therapeutics, Inc., a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, announced that the company received...
Neurocrine Biosciences, Inc., a leading neuroscience-focused biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental New Drug Application...
Menarini Silicon Biosystems, a pioneer of liquid biopsy and single cell technologies, announced the promising long-term results of the STIC trial, on OS (overall...
PAVmed Inc., a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, announced that it has entered into...
